Life Sciences

Ajax Therapeutics, Inc. Appoints Dr. David Steensma as Chief Medical Officer

Ajax Therapeutics, Inc. announced the appointment of David P. Steensma as Chief Medical Officer. Dr. David, a renowned expert in hematologic malignancies, has more than 25 years of experience and was formerly the Global Head of Hematology at Novartis Institutes for Biomedical Research, where he led early clinical development in...

August 2023

SORT BY

Alterome Therapeutics Welcomes Andrew S. Chi as Chief Medical Officer

Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development

Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer

Ankyra Therapeutics Appoints Robert V. Tighe as Chief Scientific Officer

Kytopen Appoints Michael Chiu as Chief Executive Officer

iotaSciences Appoints Dr. Michael Lutz as New Chief Executive Officer

Purespring Therapeutics Appoints Julian Hanak as Chief Executive Officer

Catena Biosciences Inc. Announces Executive Appointments

Load More